Shares of Becton Dickinson and Company (NYSE:BDX) Sees Large Outflow of Money

Becton Dickinson and Company (NYSE:BDX) jumped 1.99 points or 1.18% on strong buying and was last priced at $170.02 per share. The shares saw huge fund flow intraday; a massive $56.47 million made their way in through the upticks but an even bigger $69.47 million made their way out through downticks. As per the last observation, the net money flow stood at $(-13.01) million and the up/down ratio was found to be 0.81. The shares have seen a weekly value change of 2.55% .A block trade was recorded in the company shares with a net money flow of $(-11.2) million. The composite value of the funds in upticks was $16.53 million and the total value of funds in downticks was $27.73. As can be seen from the data, the block transaction had the up/down ratio of 0.6.


The stock has recorded a 20-day Moving Average of 1.51% and the 50-Day Moving Average is 3.75%. The company shares have rallied 17.36% in the past 52 Weeks. On June 9, 2016 The shares registered one year high of $171.64 and one year low was seen on September 28, 2015 at $128.87. The 50-day moving average is $166.62 and the 200 day moving average is recorded at $154.05. S&P 500 has rallied 1.93% during the last 52-weeks.

Becton Dickinson and Company (NYSE:BDX): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $168.55 and $168.55 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $170.68. The buying momentum continued till the end and the stock did not give up its gains. It closed at $170.02, notching a gain of 1.18% for the day. The total traded volume was 1,368,310 . The stock had closed at $168.03 on the previous day.

Currently the company Insiders own 1.6% of Becton Dickinson and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.24% . Institutional Investors own 85.48% of Becton Dickinson and Company shares. During last six month period, the net percent change held by insiders has seen a change of -21.24%. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Gallagher John E, officer (VP, Corp Finance and Treasurer) of Becton Dickinson & Co, had unloaded 1,931 shares at an average price of $169.87 in a transaction dated on June 13, 2016. The total value of the transaction was worth $328,019.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.